perflutren has been researched along with Cirrhosis, Liver in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jang, HJ; Kim, TK; Wilson, SR | 1 |
| Burns, PN; Guindi, M; Heathcote, J; Jang, HJ; Karshafian, R; Kim, TK; Tang, A; Wilson, SR | 1 |
| Barr, RG; Chammas, MC; Chaubal, NG; Chen, MH; Choi, BI; Claudon, M; Clevert, DA; Correas, JM; Cosgrove, DO; Dietrich, CF; Ding, H; Forsberg, F; Fowlkes, JB; Gibson, RN; Goldberg, BB; Kudo, M; Lassau, N; Leen, EL; Mattrey, RF; Moriyasu, F; Nolsøe, CP; Piscaglia, F; Solbiati, L; Weskott, HP; Wilson, SR; Xu, HX | 1 |
3 other study(ies) available for perflutren and Cirrhosis, Liver
| Article | Year |
|---|---|
Small nodules (1-2 cm) in liver cirrhosis: characterization with contrast-enhanced ultrasound.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Hepatocellular; Contrast Media; Female; Fluorocarbons; Humans; Image Enhancement; Liver Cirrhosis; Liver Neoplasms; Male; Middle Aged; Reproducibility of Results; Sensitivity and Specificity; Ultrasonography | 2009 |
Does hepatic vein transit time performed with contrast-enhanced ultrasound predict the severity of hepatic fibrosis?
Topics: Adult; Aged; Computer Simulation; Contrast Media; Female; Fluorocarbons; Hepatic Veins; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Liver Cirrhosis; Male; Metabolic Clearance Rate; Middle Aged; Models, Biological; Reproducibility of Results; Sensitivity and Specificity; Severity of Illness Index; Ultrasonography | 2011 |
Guidelines and good clinical practice recommendations for contrast enhanced ultrasound (CEUS) in the liver--update 2012: a WFUMB-EFSUMB initiative in cooperation with representatives of AFSUMB, AIUM, ASUM, FLAUS and ICUS.
Topics: Anaphylaxis; Biopsy, Needle; Carcinoma, Hepatocellular; Cell Transformation, Neoplastic; Contraindications; Contrast Media; Diagnosis, Differential; Drug Hypersensitivity; Drug Interactions; Ferric Compounds; Fluorocarbons; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Iron; Liver; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Liver Transplantation; Oxides; Phospholipids; Risk Factors; Sulfur Hexafluoride; Ultrasonography, Doppler; Ultrasonography, Interventional | 2013 |